UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 297

Sortiert nach

Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis

Neurology, 2008-10, Vol.71 (17), p.1350

2008

Volltextzugriff (PDF)

Optical coherence tomography assessment of disease activity in cryopyrin‐associated periodic syndrome

European journal of neurology, 2024-07, Vol.31 (7), p.e16301-n/a

2024

Volltextzugriff (PDF)

Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration

Journal of neurology, 2017, Vol.264 (1), p.139-151

2017

Volltextzugriff (PDF)

Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration

Journal of neurology, 2017-01, Vol.264 (1), p.139-151

2017

Volltextzugriff (PDF)

TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing–remitting multiple sclerosis

European journal of nuclear medicine and molecular imaging, 2018-07, Vol.45 (8), p.1423-1431

2018

Volltextzugriff (PDF)

Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS

Neurology, 2011-04, Vol.76 (14), p.1214

2011

Volltextzugriff (PDF)

MCC950 blocks enhanced interleukin-1β production in patients with NLRP3 low penetrance variants

Clinical immunology (Orlando, Fla.), 2019-06, Vol.203, p.45-52

2019

Volltextzugriff (PDF)

Cryopyrin-associated periodic fever syndrome manifesting as Tolosa-Hunt syndrome

Cephalalgia, 2016-12, Vol.36 (14), p.1392-1396

2016

Volltextzugriff (PDF)

Interferon-β increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity

Brain (London, England : 1878), 2008-06, Vol.131 (6), p.1455-1463

2008

Volltextzugriff (PDF)

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing

Journal of neuroinflammation, 2018-05, Vol.15 (1), p.134-134, Article 134

2018

Volltextzugriff (PDF)

Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters

Multiple sclerosis, 2002-12, Vol.8 (6), p.523-526

2002

Volltextzugriff (PDF)

Inner retinal layer thinning in radiologically isolated syndrome predicts conversion to multiple sclerosis

European journal of neurology, 2020-11, Vol.27 (11), p.2217-2224

2020

Volltextzugriff (PDF)

Characteristic retinal atrophy pattern allows differentiation between pediatric MOGAD and MS after a single optic neuritis episode

Journal of neurology, 2022-12, Vol.269 (12), p.6366-6376

2022

Volltextzugriff (PDF)

Clinical onset of CNS demyelinating disease after COVID-19 vaccination: denovo disease?

Multiple sclerosis and related disorders, 2022-11, Vol.67, p.104175-104175, Article 104175

2022

Volltextzugriff (PDF)

Magnetic Resonance Imaging Characteristics of Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic Manifestations

Clinical neuroradiology (Munich), 2020-06, Vol.30 (2), p.229-236

2020

Volltextzugriff (PDF)

Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID)

Journal of neuroimmune pharmacology, 2016-03, Vol.11 (1), p.1-8

2016

Volltextzugriff (PDF)

NMOSD triggered by yellow fever vaccination – an unusual clinical presentation with segmental painful erythema

Multiple sclerosis and related disorders, 2017-01, Vol.11, p.43-44

2017

Volltextzugriff (PDF)

Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosis

Multiple sclerosis, 2012-09, Vol.18 (9), p.1229-1238

2012

Volltextzugriff (PDF)

Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases

Neurology, 2008-11, Vol.71 (22), p.1812

2008

Volltextzugriff (PDF)

Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab “infusion group”

Multiple sclerosis, 2013-08, Vol.19 (9), p.1213-1215

2013

Volltextzugriff (PDF)

Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS

Journal of neuroinflammation, 2015-12, Vol.12 (232), p.234-234, Article 234

2015

Volltextzugriff (PDF)

TNFRSF1A R92Q mutation in association with a multiple sclerosis-like demyelinating syndrome

Neurology, 2008-03, Vol.70 (13 Pt 2), p.1155

2008

Volltextzugriff (PDF)

Drug-induced Sweet’s syndrome after mitoxantrone therapy in a patient with multiple sclerosis

Multiple sclerosis, 2011-04, Vol.17 (4), p.495-497

2011

Volltextzugriff (PDF)

Treatment with glatiramer acetate induces specific IgG4 antibodies in multiple sclerosis patients

Journal of neuroimmunology, 2002-02, Vol.123 (1), p.188-192

2002

Volltextzugriff (PDF)

Identification of the flotillin-1/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis

Journal of neuroinflammation, 2017-06, Vol.14 (1), p.123-123, Article 123

2017

Volltextzugriff (PDF)

1 – 25 von 297

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(281)
Mit Volltextzugriff
(266)

Publikationsform

Sprache

Englisch
(257)
Deutsch
(41)
Japanisch
(31)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Nervenarzt
(30)
Multiple Sclerosis
(22)
Neurology : Neuroimmunology & Neuroinflammation
(22)
Journal Of Neurology
(18)
Neurology® Neuroimmunology & Neuroinflammation
(16)
Neurology
(12)
Annals Of Neurology
(11)
Brain
(10)
Journal Of Neuroinflammation
(10)
Acta Polymerica
(8)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis

Optical coherence tomography assessment of disease activity in cryopyrin‐associated periodic syndrome

Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration

Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration

TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing–remitting multiple sclerosis

Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS

MCC950 blocks enhanced interleukin-1β production in patients with NLRP3 low penetrance variants

Cryopyrin-associated periodic fever syndrome manifesting as Tolosa-Hunt syndrome

Interferon-β increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing

Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters

Inner retinal layer thinning in radiologically isolated syndrome predicts conversion to multiple sclerosis

Characteristic retinal atrophy pattern allows differentiation between pediatric MOGAD and MS after a single optic neuritis episode

Clinical onset of CNS demyelinating disease after COVID-19 vaccination: denovo disease?

Magnetic Resonance Imaging Characteristics of Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic Manifestations

Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID)

NMOSD triggered by yellow fever vaccination – an unusual clinical presentation with segmental painful erythema

Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosis

Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases

Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab “infusion group”

Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS

TNFRSF1A R92Q mutation in association with a multiple sclerosis-like demyelinating syndrome

Drug-induced Sweet’s syndrome after mitoxantrone therapy in a patient with multiple sclerosis

Treatment with glatiramer acetate induces specific IgG4 antibodies in multiple sclerosis patients

Identification of the flotillin-1/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis

Suchergebnisse filtern